Anna M Pyle - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Anna M Pyle

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Cancer Research|September 19, 2018

Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast CancersDavid L Elion, Max E Jacobson, Donna J Hicks, et al.

ACS Central Science|December 4, 2020

Structural Optimization of Polymeric Carriers to Enhance the Immunostimulatory Activity of Molecularly Defined RIG-I AgonistsMax E Jacobson, Kyle W Becker, Christian R Palmer, et al.

Advanced Healthcare Materials|April 22, 2024

Covalent Polymer-RNA Conjugates for Potent Activation of the RIG-I PathwayChristian R Palmer, Lucinda E Pastora, Blaise R Kimmel, et al.

Biorxiv : the Preprint Server for Biology|June 23, 2021

A stem-loop RNA RIG-I agonist confers prophylactic and therapeutic protection against acute and chronic SARS-CoV-2 infection in miceTianyang Mao, Benjamin Israelow, Carolina Lucas, et al.

The Journal of Experimental Medicine|November 10, 2021

A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in miceTianyang Mao, Benjamin Israelow, Carolina Lucas, et al.

Journal of the American Chemical Society|May 30, 2024

Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain CancersEric D Huseman, Anna Lo, Olga Fedorova, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Cancer Research|September 19, 2018

Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast CancersDavid L Elion, Max E Jacobson, Donna J Hicks, et al.

ACS Central Science|December 4, 2020

Structural Optimization of Polymeric Carriers to Enhance the Immunostimulatory Activity of Molecularly Defined RIG-I AgonistsMax E Jacobson, Kyle W Becker, Christian R Palmer, et al.

Advanced Healthcare Materials|April 22, 2024

Covalent Polymer-RNA Conjugates for Potent Activation of the RIG-I PathwayChristian R Palmer, Lucinda E Pastora, Blaise R Kimmel, et al.

Biorxiv : the Preprint Server for Biology|June 23, 2021

A stem-loop RNA RIG-I agonist confers prophylactic and therapeutic protection against acute and chronic SARS-CoV-2 infection in miceTianyang Mao, Benjamin Israelow, Carolina Lucas, et al.

The Journal of Experimental Medicine|November 10, 2021

A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in miceTianyang Mao, Benjamin Israelow, Carolina Lucas, et al.

Journal of the American Chemical Society|May 30, 2024

Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain CancersEric D Huseman, Anna Lo, Olga Fedorova, et al.

Pageof 3